Cell Cycle/Checkpoint
Cell Cycle/Checkpoint(细胞周期/检查点)
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0. read more
- ATM/ATR(29)
- Aurora Kinase(58)
- Cdc42(4)
- Cdc7(3)
- Chk(14)
- c-Myc(27)
- CRM1(8)
- Cyclin-Dependent Kinases(77)
- E1 enzyme(1)
- G-quadruplex(12)
- Haspin(6)
- HMTase(1)
- Kinesin(27)
- Ksp(4)
- Microtubule/Tubulin(257)
- Mps1(15)
- Mitotic(7)
- RAD51(13)
- ROCK(74)
- Rho(13)
- PERK(11)
- PLK(43)
- PTEN(6)
- Wee1(9)
- PAK(25)
- Arp2/3 Complex(8)
- Dynamin(14)
- ECM & Adhesion Molecules(54)
- Cytoskeleton & Motor Proteins(65)
- Endomembrane System & Vesicular Trafficking(36)
- G1(51)
- Genotoxic Stress(23)
- G2/M(40)
- G2/S(17)
- Inositol Phosphates(67)
- Proteolysis(183)
- Cellular Chaperones(14)
- Cyclin G-associated Kinase (GAK)(1)
- MARK(3)
- NEKs(1)
Cell Cycle/Checkpoint 相关产品(1379)
- GC12092TMPyP4 tosylateCAS: 36951-72-1纯度: >98.00% / >95.00%
TMPyP4 tosylate是一种四链体特异性配体,可以抑制G-四链体与胰岛素样生长因子I(IGF-1)之间的相互作用。
- GC12338WortmanninCAS: 19545-26-7纯度: >99.50% / >98.00% / >99.00%
渥曼青霉素是一种高效的 PI3 激酶特异性直接抑制剂,最初源自真菌 (1,2)。
- GC12425CDK inhibitor IICAS: 1269815-17-9纯度: >98.50%
CDK inhibitor II 是一种有效且特异性的 CDK9 抑制剂,IC50 <8 nM,取自参考文献 1,实施例 4。
- GC12690MLN8237 (Alisertib)CAS: 1028486-01-2纯度: >99.00%
Alisertib (MLN8237) 作为一种在研、可口服的选择性极光 A 激酶抑制剂,通常用于治疗实体瘤和血液系统恶性肿瘤。
- GC12817K-115 hydrochloride dihydrateCAS: 887375-67-9纯度: >99.50%
K-115 hydrochloride dihydrate (K-115) 是 ROCK 的特异性抑制剂,对 ROCK2 和 ROCK1 的 IC50 分别为 19 和 51 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC11905 | Cevipabulin | 849550-05-6 | >99.50% | |
An activator of microtubule polymerization | ||||
| GC11944 | PF 4800567 hydrochloride | 1391052-28-0 | - | |
A selective CK1ε inhibitor | ||||
| GC11947 | Ansamitocin P-3 | 66547-09-9 | >98.00% | |
A microtubule depolymerizing agent | ||||
| GC11971 | LY2857785 | 1619903-54-6 | >98.50% | |
A Cdk9 inhibitor | ||||
| GC12001 | BS-181 | 1092443-52-1 | - | |
A selective Cdk7 inhibitor | ||||
| GC12064 | SB1317 | 937270-47-8 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC12092 | TMPyP4 tosylate | 36951-72-1 | >98.00% / >95.00% | |
TMPyP4 tosylate是一种四链体特异性配体,可以抑制G-四链体与胰岛素样生长因子I(IGF-1)之间的相互作用。 | ||||
| GC12286 | Vinblastine sulfate | 143-67-9 | >99.50% / >98.00% | |
Vinblastine sulfate是一种细胞毒性生物碱。 | ||||
| GC12314 | 3-(4-Pyridyl)indole | 7272-84-6 | >98.00% | |
A ROCK1 and ROCK2 inhibitor | ||||
| GC12319 | Ferulenol | 6805-34-1 | >95.00% | |
A prenylated 4-hydroxycoumarin | ||||
| GC12338 | Wortmannin | 19545-26-7 | >99.50% / >98.00% / >99.00% | |
渥曼青霉素是一种高效的 PI3 激酶特异性直接抑制剂,最初源自真菌 (1,2)。 | ||||
| GC12348 | Ro 3306 | 872573-93-8 | >98.00% | |
Ro 3306是一种ATP竞争性抑制剂,主要靶向CDK1/cyclin B1(K i 值为35nmol/L)和CDK1/cyclin A复合物(K i 值为110nmol/L)。 | ||||
| GC12352 | cis-trismethoxy Resveratrol | 94608-23-8 | >98.00% | |
Potent antineoplastic agent | ||||
| GC12402 | LX7101 HCL | 1192189-69-7 | >99.50% | |
A LIMK and ROCK inhibitor | ||||
| GC12425 | CDK inhibitor II | 1269815-17-9 | >98.50% | |
CDK inhibitor II 是一种有效且特异性的 CDK9 抑制剂,IC50 <8 nM,取自参考文献 1,实施例 4。 | ||||
| GC12450 | BI 2536 | 755038-02-9 | >99.50% / >98.00% | |
BI 2536是一种双重Polo样激酶(PLK)/溴结构域抑制剂,在无细胞激酶实验中,BI 2536 对PLK1、PLK2和PLK3的半数抑制浓度(IC 50 )值分别为0.83nM、3.5nM和9.0nM。 | ||||
| GC12604 | Fumonisin B1 | 116355-83-0 | >98.00% / >95.00% | |
A mycotoxin | ||||
| GC12690 | MLN8237 (Alisertib) | 1028486-01-2 | >99.00% | |
Alisertib (MLN8237) 作为一种在研、可口服的选择性极光 A 激酶抑制剂,通常用于治疗实体瘤和血液系统恶性肿瘤。 | ||||
| GC12752 | RI-2 | 1417162-36-7 | >99.50% | |
A RAD51 inhibitor | ||||
| GC12788 | Paprotrain | 57046-73-8 | >99.50% | |
A MKLP-2 inhibitor | ||||
| GC12795 | CCG-1423 | 285986-88-1 | >99.50% | |
An inhibitor of Rho-mediated cell signalling | ||||
| GC12817 | K-115 hydrochloride dihydrate | 887375-67-9 | >99.50% | |
K-115 hydrochloride dihydrate (K-115) 是 ROCK 的特异性抑制剂,对 ROCK2 和 ROCK1 的 IC50 分别为 19 和 51 nM。 | ||||
| GC12826 | AZD-5597 | 924641-59-8 | - | |
Potent CDK inhibitor | ||||
| GC12865 | BMS265246 | 582315-72-8 | >99.00% | |
A cell-permeable inhibitor of Cdk1 and Cdk2 | ||||
